Peer-Review Report of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10012)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 27, 2022 (publication date) through Apr 21, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Rai V, Mukherjee S. Targets of immunotherapy for hepatocellular carcinoma: An update. World J Hepatol 2022; 14(1): 140-157 [PMID: 35126844 DOI: 10.4254/wjh.v14.i1.140] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Rai V, Mukherjee S. Targets of immunotherapy for hepatocellular carcinoma: An update. World J Hepatol 2022; 14(1): 140-157 [PMID: 35126844 DOI: 10.4254/wjh.v14.i1.140] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i1/140.htm |
| Number | Citing Articles |
| 1 |
Jun Huang, Chunbei Zhao, Xinhe Zhang, Qiaohui Zhao, Yanting Zhang, Liping Chen, Guifu Dai. Hepatitis B virus pathogenesis relevant immunosignals uncovering amino acids utilization related risk factors guide artificial intelligence-based precision medicine. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1079566
|
| 2 |
Lichen Zhou, Wenjie Zhang, Zhuoran Liu, Yaming Xie, Kangyi Jiang. Immune cell metabolic reprogramming in hepatocellular carcinoma: mechanisms, tumor microenvironment, and future immunotherapeutic directions. Frontiers in Immunology 2026; 16 doi: 10.3389/fimmu.2025.1697675
|
| 3 |
Peidong Miao, Chunxia Pan, Tianyu Li, Ying Li. Potential role of immune-related LncRNAs in prognosis of hepatocellular carcinoma: an integrative study. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03497-w
|
| 4 |
Faris Alrumaihi. Role of Liquid Biopsy for Early Detection, Prognosis, and Therapeutic Monitoring of Hepatocellular Carcinoma. Diagnostics 2025; 15(13): 1655 doi: 10.3390/diagnostics15131655
|
| 5 |
Giulia Milardi, Ana Lleo. Tumor-Infiltrating B Lymphocytes: Promising Immunotherapeutic Targets for Primary Liver Cancer Treatment. Cancers 2023; 15(7): 2182 doi: 10.3390/cancers15072182
|
| 6 |
Vikrant Rai. Cancer Treatment. Handbook of Cancer and Immunology 2025; 7: 97 doi: 10.1007/978-3-032-00769-8_221
|
| 7 |
Jinyi Zhu, Wenze Wu. Clinical Analysis of Transcatheter Arterial Chemoembolization Sequential Microwave Ablation Combined with Targeted Therapy and Immunotherapy in the Treatment of Large Hepatocellular Carcinoma. Journal of Biosciences and Medicines 2023; 11(01): 18 doi: 10.4236/jbm.2023.111003
|
| 8 |
Zhuoyang Fan, Bowen Yin, Xiaochen Chen, Guowei Yang, Wei Zhang, Xiaodan Ye, Hong Han, Ming Li, Minfeng Shu, Rong Liu. Comprehensive analysis of paraspeckle-associated gene modules unveils prognostic signatures and immunological relevance in multi-cancers. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01188-6
|
| 9 |
Haiwei Zhang, Juan Zhao, Wei Yang, Zheng Li, Li Gong, Yongsheng Li. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 3: 41 doi: 10.1007/16833_2022_96
|
| 10 |
Elias Kouroumalis, Ioannis Tsomidis, Argryro Voumvouraki. Is There a Place for Somatostatin Analogues for the Systemic Treatment of Hepatocellular Carcinoma in the Immunotherapy Era?. Livers 2022; 2(4): 315 doi: 10.3390/livers2040024
|
| 11 |
|
| 12 |
Mengxing Cai, Jingwen Luo, Chunxiu Yang, Xiaopeng Yang, Cheng Zhang, Lixin Ma, Yibin Cheng. ABHD12 contributes to tumorigenesis and sorafenib resistance by preventing ferroptosis in hepatocellular carcinoma. iScience 2023; 26(12): 108340 doi: 10.1016/j.isci.2023.108340
|